These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35835062)

  • 21. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
    Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
    Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs.
    Gaillard S; Roche L; Lemoine S; Deschênes G; Morin D; Vianey-Saban C; Acquaviva-Bourdain C; Ranchin B; Bacchetta J; Kassai B; Nony P; Bodénan E; Laudy V; Rouges C; Zarrabian S; Subtil F; Mercier C; Cochat P; Bertholet-Thomas A
    Pediatr Nephrol; 2021 Mar; 36(3):581-589. PubMed ID: 32901297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
    Sonies BC; Almajid P; Kleta R; Bernardini I; Gahl WA
    Medicine (Baltimore); 2005 May; 84(3):137-146. PubMed ID: 15879904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrarenal complications of cystinosis.
    Topaloglu R
    Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.
    Kimonis VE; Troendle J; Rose SR; Yang ML; Markello TC; Gahl WA
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3257-61. PubMed ID: 7593434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephropathic cystinosis in Poland: a 40-year retrospective study.
    Sikora P; Grenda R; Kowalczyk M; Kieć-Wilk B; Bieniaś B; Rubik J; Szymczak M; Nosek H; Surowiec P; Marquardt T; Beck BB; Zaniew M
    Pol Arch Intern Med; 2022 Nov; 132(11):. PubMed ID: 35997069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NIH conference. Cystinosis: progress in a prototypic disease.
    Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
    Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
    Kluck R; Müller S; Jagodzinski C; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Hagenberg M; Kanzelmeyer N; Pavičić L; Haffner D; Zivicnjak M
    J Inherit Metab Dis; 2022 Mar; 45(2):192-202. PubMed ID: 34989402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephropathic cystinosis: late complications of a multisystemic disease.
    Nesterova G; Gahl W
    Pediatr Nephrol; 2008 Jun; 23(6):863-78. PubMed ID: 18008091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of bone disease in cystinosis: Statement from an international conference.
    Hohenfellner K; Rauch F; Ariceta G; Awan A; Bacchetta J; Bergmann C; Bechtold S; Cassidy N; Deschenes G; Elenberg E; Gahl WA; Greil O; Harms E; Herzig N; Hoppe B; Koeppl C; Lewis MA; Levtchenko E; Nesterova G; Santos F; Schlingmann KP; Servais A; Soliman NA; Steidle G; Sweeney C; Treikauskas U; Topaloglu R; Tsygin A; Veys K; V Vigier R; Zustin J; Haffner D
    J Inherit Metab Dis; 2019 Sep; 42(5):1019-1029. PubMed ID: 31177550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study.
    Bjerre A; Aase SA; Radtke M; Siva C; Gudmundsdottir H; Forsberg B; Woldseth B; Brackman D
    Pediatr Nephrol; 2023 Nov; 38(11):3671-3679. PubMed ID: 37219641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy.
    Tsilou ET; Rubin BI; Reed G; Caruso RC; Iwata F; Balog J; Gahl WA; Kaiser-Kupfer MI
    Ophthalmology; 2006 Jun; 113(6):1002-9. PubMed ID: 16603246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
    Dohil R; Cabrera BL
    Pediatr Nephrol; 2013 Mar; 28(3):507-10. PubMed ID: 23001048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis.
    Elkhateeb N; Selim R; Soliman NA; Atia FM; Abouelwoun II; Elmonem MA; Helmy R
    Pediatr Nephrol; 2022 Jul; 37(7):1555-1566. PubMed ID: 34791528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
    Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
    Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newborn Screening: Review of its Impact for Cystinosis.
    Hohenfellner K; Elenberg E; Ariceta G; Nesterova G; Soliman NA; Topaloglu R
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nephropathic cystinosis: report of 2 cases and review of the literature].
    Knoepfelmacher M; Rocha R; Salgado LR; Semer M; Voss D; Wajchenberg BL; Liberman B
    Rev Assoc Med Bras (1992); 1994; 40(1):43-6. PubMed ID: 8061694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.